Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy
This report evaluated sirolimus-eluting stent implantation to treat recurrent in-stent restenosis after failed brachytherapy in 12 consecutive patients. This strategy appeared to be safe and clinically effective, although the high rate of angiographic restenosis observed suggests a reduced efficacy...
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2003-07, Vol.92 (2), p.200-203 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 203 |
|---|---|
| container_issue | 2 |
| container_start_page | 200 |
| container_title | The American journal of cardiology |
| container_volume | 92 |
| creator | Saia, Francesco Lemos, Pedro A. Sianos, Georgios Degertekin, Muzaffer Lee, Chi-Hang Arampatzis, Chourmouzios A. Hoye, Angela Tanabe, Kengo Regar, Evelyn van der Giessen, Willem J. Smits, Pieter C. de Feyter, Pim Ligthart, Jurghen van Domburg, Ron T. Serruys, Patrick W. |
| description | This report evaluated sirolimus-eluting stent implantation to treat recurrent in-stent restenosis after failed brachytherapy in 12 consecutive patients. This strategy appeared to be safe and clinically effective, although the high rate of angiographic restenosis observed suggests a reduced efficacy of rapamycin to prevent neointimal hyperplasia in this setting compared with the treatment of de novo lesions. |
| doi_str_mv | 10.1016/S0002-9149(03)00538-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73475256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914903005381</els_id><sourcerecordid>394590291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-232a298af93dc3863a81a63e0252eca0c402730830c2fea655ea6e7b835400ad3</originalsourceid><addsrcrecordid>eNqFkU9r3DAQxUVoSTbbfIQUU2hpD05GkmXLp1BC0hYCPaQ5C608apTa0laSA_vtq_1DA730MsOg34we7xFyTuGCAm0v7wGA1T1t-o_APwEILmt6RBZUdn1Ne8pfkcVf5IScpvRURkpFe0xOKJMtMNYsyK8ba9Fk94weU6qCrZKLYXTTnGoc5-z8zypl9Lly03rUPuvsgq9siFVEM8e4e_L1nom47SG5VGmbMVarqM3jJj9i1OvNG_La6jHh2aEvycPtzY_rr_Xd9y_frj_f1aahMteMM816qW3PB8Nly7WkuuUITDA0GkwDrOMgORhmUbdClILdSnLRAOiBL8mH_d11DL_nIklNLhkci3wMc1IdbzrBRFvAd_-AT2GOvmhTjAPvgJVflkTsIRNDShGtWkc36bhRFNQ2CrWLQm19VsDVLgpFy97bw_F5NeHwsnXwvgDvD4BORo82am9ceuGaXkLb8cJd7Tksnj07jCoZh97g4EoEWQ3B_UfKH4Nwpsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230370208</pqid></control><display><type>article</type><title>Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Saia, Francesco ; Lemos, Pedro A. ; Sianos, Georgios ; Degertekin, Muzaffer ; Lee, Chi-Hang ; Arampatzis, Chourmouzios A. ; Hoye, Angela ; Tanabe, Kengo ; Regar, Evelyn ; van der Giessen, Willem J. ; Smits, Pieter C. ; de Feyter, Pim ; Ligthart, Jurghen ; van Domburg, Ron T. ; Serruys, Patrick W.</creator><creatorcontrib>Saia, Francesco ; Lemos, Pedro A. ; Sianos, Georgios ; Degertekin, Muzaffer ; Lee, Chi-Hang ; Arampatzis, Chourmouzios A. ; Hoye, Angela ; Tanabe, Kengo ; Regar, Evelyn ; van der Giessen, Willem J. ; Smits, Pieter C. ; de Feyter, Pim ; Ligthart, Jurghen ; van Domburg, Ron T. ; Serruys, Patrick W.</creatorcontrib><description>This report evaluated sirolimus-eluting stent implantation to treat recurrent in-stent restenosis after failed brachytherapy in 12 consecutive patients. This strategy appeared to be safe and clinically effective, although the high rate of angiographic restenosis observed suggests a reduced efficacy of rapamycin to prevent neointimal hyperplasia in this setting compared with the treatment of de novo lesions.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(03)00538-1</identifier><identifier>PMID: 12860224</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Aged ; Biological and medical sciences ; Blood Vessel Prosthesis Implantation ; Brachytherapy ; Cardiovascular disease ; Diseases of the cardiovascular system ; Effectiveness ; Female ; Follow-Up Studies ; Graft Occlusion, Vascular - drug therapy ; Graft Occlusion, Vascular - prevention & control ; Graft Occlusion, Vascular - radiotherapy ; Humans ; Immunosuppressive Agents - administration & dosage ; Immunosuppressive Agents - therapeutic use ; Male ; Medical sciences ; Middle Aged ; Outcome Assessment (Health Care) ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Secondary Prevention ; Sirolimus - administration & dosage ; Sirolimus - therapeutic use ; Stents ; Treatment Failure</subject><ispartof>The American journal of cardiology, 2003-07, Vol.92 (2), p.200-203</ispartof><rights>2003 Excerpta Medica Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Jul 15, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-232a298af93dc3863a81a63e0252eca0c402730830c2fea655ea6e7b835400ad3</citedby><cites>FETCH-LOGICAL-c418t-232a298af93dc3863a81a63e0252eca0c402730830c2fea655ea6e7b835400ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0002-9149(03)00538-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14980673$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12860224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saia, Francesco</creatorcontrib><creatorcontrib>Lemos, Pedro A.</creatorcontrib><creatorcontrib>Sianos, Georgios</creatorcontrib><creatorcontrib>Degertekin, Muzaffer</creatorcontrib><creatorcontrib>Lee, Chi-Hang</creatorcontrib><creatorcontrib>Arampatzis, Chourmouzios A.</creatorcontrib><creatorcontrib>Hoye, Angela</creatorcontrib><creatorcontrib>Tanabe, Kengo</creatorcontrib><creatorcontrib>Regar, Evelyn</creatorcontrib><creatorcontrib>van der Giessen, Willem J.</creatorcontrib><creatorcontrib>Smits, Pieter C.</creatorcontrib><creatorcontrib>de Feyter, Pim</creatorcontrib><creatorcontrib>Ligthart, Jurghen</creatorcontrib><creatorcontrib>van Domburg, Ron T.</creatorcontrib><creatorcontrib>Serruys, Patrick W.</creatorcontrib><title>Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>This report evaluated sirolimus-eluting stent implantation to treat recurrent in-stent restenosis after failed brachytherapy in 12 consecutive patients. This strategy appeared to be safe and clinically effective, although the high rate of angiographic restenosis observed suggests a reduced efficacy of rapamycin to prevent neointimal hyperplasia in this setting compared with the treatment of de novo lesions.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Blood Vessel Prosthesis Implantation</subject><subject>Brachytherapy</subject><subject>Cardiovascular disease</subject><subject>Diseases of the cardiovascular system</subject><subject>Effectiveness</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Graft Occlusion, Vascular - drug therapy</subject><subject>Graft Occlusion, Vascular - prevention & control</subject><subject>Graft Occlusion, Vascular - radiotherapy</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Outcome Assessment (Health Care)</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Secondary Prevention</subject><subject>Sirolimus - administration & dosage</subject><subject>Sirolimus - therapeutic use</subject><subject>Stents</subject><subject>Treatment Failure</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9r3DAQxUVoSTbbfIQUU2hpD05GkmXLp1BC0hYCPaQ5C608apTa0laSA_vtq_1DA730MsOg34we7xFyTuGCAm0v7wGA1T1t-o_APwEILmt6RBZUdn1Ne8pfkcVf5IScpvRURkpFe0xOKJMtMNYsyK8ba9Fk94weU6qCrZKLYXTTnGoc5-z8zypl9Lly03rUPuvsgq9siFVEM8e4e_L1nom47SG5VGmbMVarqM3jJj9i1OvNG_La6jHh2aEvycPtzY_rr_Xd9y_frj_f1aahMteMM816qW3PB8Nly7WkuuUITDA0GkwDrOMgORhmUbdClILdSnLRAOiBL8mH_d11DL_nIklNLhkci3wMc1IdbzrBRFvAd_-AT2GOvmhTjAPvgJVflkTsIRNDShGtWkc36bhRFNQ2CrWLQm19VsDVLgpFy97bw_F5NeHwsnXwvgDvD4BORo82am9ceuGaXkLb8cJd7Tksnj07jCoZh97g4EoEWQ3B_UfKH4Nwpsg</recordid><startdate>20030715</startdate><enddate>20030715</enddate><creator>Saia, Francesco</creator><creator>Lemos, Pedro A.</creator><creator>Sianos, Georgios</creator><creator>Degertekin, Muzaffer</creator><creator>Lee, Chi-Hang</creator><creator>Arampatzis, Chourmouzios A.</creator><creator>Hoye, Angela</creator><creator>Tanabe, Kengo</creator><creator>Regar, Evelyn</creator><creator>van der Giessen, Willem J.</creator><creator>Smits, Pieter C.</creator><creator>de Feyter, Pim</creator><creator>Ligthart, Jurghen</creator><creator>van Domburg, Ron T.</creator><creator>Serruys, Patrick W.</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20030715</creationdate><title>Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy</title><author>Saia, Francesco ; Lemos, Pedro A. ; Sianos, Georgios ; Degertekin, Muzaffer ; Lee, Chi-Hang ; Arampatzis, Chourmouzios A. ; Hoye, Angela ; Tanabe, Kengo ; Regar, Evelyn ; van der Giessen, Willem J. ; Smits, Pieter C. ; de Feyter, Pim ; Ligthart, Jurghen ; van Domburg, Ron T. ; Serruys, Patrick W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-232a298af93dc3863a81a63e0252eca0c402730830c2fea655ea6e7b835400ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Blood Vessel Prosthesis Implantation</topic><topic>Brachytherapy</topic><topic>Cardiovascular disease</topic><topic>Diseases of the cardiovascular system</topic><topic>Effectiveness</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Graft Occlusion, Vascular - drug therapy</topic><topic>Graft Occlusion, Vascular - prevention & control</topic><topic>Graft Occlusion, Vascular - radiotherapy</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Outcome Assessment (Health Care)</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Secondary Prevention</topic><topic>Sirolimus - administration & dosage</topic><topic>Sirolimus - therapeutic use</topic><topic>Stents</topic><topic>Treatment Failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saia, Francesco</creatorcontrib><creatorcontrib>Lemos, Pedro A.</creatorcontrib><creatorcontrib>Sianos, Georgios</creatorcontrib><creatorcontrib>Degertekin, Muzaffer</creatorcontrib><creatorcontrib>Lee, Chi-Hang</creatorcontrib><creatorcontrib>Arampatzis, Chourmouzios A.</creatorcontrib><creatorcontrib>Hoye, Angela</creatorcontrib><creatorcontrib>Tanabe, Kengo</creatorcontrib><creatorcontrib>Regar, Evelyn</creatorcontrib><creatorcontrib>van der Giessen, Willem J.</creatorcontrib><creatorcontrib>Smits, Pieter C.</creatorcontrib><creatorcontrib>de Feyter, Pim</creatorcontrib><creatorcontrib>Ligthart, Jurghen</creatorcontrib><creatorcontrib>van Domburg, Ron T.</creatorcontrib><creatorcontrib>Serruys, Patrick W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saia, Francesco</au><au>Lemos, Pedro A.</au><au>Sianos, Georgios</au><au>Degertekin, Muzaffer</au><au>Lee, Chi-Hang</au><au>Arampatzis, Chourmouzios A.</au><au>Hoye, Angela</au><au>Tanabe, Kengo</au><au>Regar, Evelyn</au><au>van der Giessen, Willem J.</au><au>Smits, Pieter C.</au><au>de Feyter, Pim</au><au>Ligthart, Jurghen</au><au>van Domburg, Ron T.</au><au>Serruys, Patrick W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2003-07-15</date><risdate>2003</risdate><volume>92</volume><issue>2</issue><spage>200</spage><epage>203</epage><pages>200-203</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>This report evaluated sirolimus-eluting stent implantation to treat recurrent in-stent restenosis after failed brachytherapy in 12 consecutive patients. This strategy appeared to be safe and clinically effective, although the high rate of angiographic restenosis observed suggests a reduced efficacy of rapamycin to prevent neointimal hyperplasia in this setting compared with the treatment of de novo lesions.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>12860224</pmid><doi>10.1016/S0002-9149(03)00538-1</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2003-07, Vol.92 (2), p.200-203 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73475256 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Aged Biological and medical sciences Blood Vessel Prosthesis Implantation Brachytherapy Cardiovascular disease Diseases of the cardiovascular system Effectiveness Female Follow-Up Studies Graft Occlusion, Vascular - drug therapy Graft Occlusion, Vascular - prevention & control Graft Occlusion, Vascular - radiotherapy Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - therapeutic use Male Medical sciences Middle Aged Outcome Assessment (Health Care) Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Secondary Prevention Sirolimus - administration & dosage Sirolimus - therapeutic use Stents Treatment Failure |
| title | Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T10%3A38%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20sirolimus-eluting%20stent%20implantation%20for%20recurrent%20in-stent%20restenosis%20after%20brachytherapy&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Saia,%20Francesco&rft.date=2003-07-15&rft.volume=92&rft.issue=2&rft.spage=200&rft.epage=203&rft.pages=200-203&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(03)00538-1&rft_dat=%3Cproquest_cross%3E394590291%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230370208&rft_id=info:pmid/12860224&rft_els_id=S0002914903005381&rfr_iscdi=true |